DK0613894T3 - N-Heteroaryl-N'-phenylurinstofderivater, fremstilling og anvendelse deraf - Google Patents
N-Heteroaryl-N'-phenylurinstofderivater, fremstilling og anvendelse derafInfo
- Publication number
- DK0613894T3 DK0613894T3 DK94102905T DK94102905T DK0613894T3 DK 0613894 T3 DK0613894 T3 DK 0613894T3 DK 94102905 T DK94102905 T DK 94102905T DK 94102905 T DK94102905 T DK 94102905T DK 0613894 T3 DK0613894 T3 DK 0613894T3
- Authority
- DK
- Denmark
- Prior art keywords
- garyl
- heter
- preparation
- phenylurea derivatives
- phenylurea
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/40—Nitrogen atoms, not forming part of a nitro radical, e.g. isatin semicarbazone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/92—Naphthofurans; Hydrogenated naphthofurans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/66—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/74—Naphthothiophenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/78—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pyridine Compounds (AREA)
- Furan Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6346093 | 1993-02-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0613894T3 true DK0613894T3 (da) | 1999-11-01 |
Family
ID=13229879
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK94102905T DK0613894T3 (da) | 1993-02-27 | 1994-02-25 | N-Heteroaryl-N'-phenylurinstofderivater, fremstilling og anvendelse deraf |
Country Status (14)
Country | Link |
---|---|
US (2) | US5464863A (fr) |
EP (1) | EP0613894B1 (fr) |
JP (1) | JP3143766B2 (fr) |
KR (1) | KR940019701A (fr) |
CN (1) | CN1051311C (fr) |
AT (1) | ATE179706T1 (fr) |
AU (1) | AU679021B2 (fr) |
CA (1) | CA2116286A1 (fr) |
DE (1) | DE69418243T2 (fr) |
DK (1) | DK0613894T3 (fr) |
ES (1) | ES2133430T3 (fr) |
GR (1) | GR3030165T3 (fr) |
NZ (1) | NZ250916A (fr) |
TW (1) | TW279858B (fr) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW234123B (fr) * | 1992-12-16 | 1994-11-11 | Takeda Pharm Industry Co Ltd | |
NZ264063A (en) * | 1993-08-13 | 1995-11-27 | Nihon Nohyaku Co Ltd | N-(2-phenylpyrid-3-yl)- and n-(4-phenylpyrimidin-5-yl)-n'-phenylurea derivatives and pharmaceutical compositions |
FR2734816B1 (fr) * | 1995-05-31 | 1997-07-04 | Adir | Nouveaux aryl (alkyl) propylamides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
US5773459A (en) * | 1995-06-07 | 1998-06-30 | Sugen, Inc. | Urea- and thiourea-type compounds |
US5606075A (en) * | 1995-06-07 | 1997-02-25 | Eli Lilly And Company | Process for the synthesis of benzo[b]thiophenes |
US5567828A (en) * | 1995-06-07 | 1996-10-22 | Eli Lilly And Company | Compounds and compositions with nitrogen-containing non-basic side |
AU679887B2 (en) * | 1995-09-11 | 1997-07-10 | Nihon Nohyaku Co., Ltd. | Azole derivatives, their use, production and usage |
WO1997049287A1 (fr) * | 1996-06-27 | 1997-12-31 | Smithkline Beecham Corporation | Antagonistes des recepteurs d'il-8 |
TW415942B (en) * | 1997-09-03 | 2000-12-21 | American Home Prod | Novel substituted 1-aryl-3-heteroaryl-thioureas and substituted 1-aryl-3-heteroaryl-isothioureas as antiatherosclerotic agents |
US6455566B1 (en) | 1997-09-03 | 2002-09-24 | Wyeth | Substituted 1-aryl-3-heteroaryl-thioureas (or isothioureas) as antiatherosclerotic agents |
JP2002529444A (ja) * | 1998-11-12 | 2002-09-10 | アリアド・ファーマシューティカルズ・インコーポレイテッド | 二環式シグナル伝達阻害剤、それを含む組成物とその用途 |
CN1441794A (zh) * | 2000-07-13 | 2003-09-10 | 武田药品工业株式会社 | 富脂质斑退化剂 |
EP1341761A1 (fr) | 2000-10-10 | 2003-09-10 | Smithkline Beecham Corporation | Indoles substituees, compositions pharmaceutiques contenant ces indoles et leur utilisation comme agent de fixation de ppar-$g(g) |
AU2002221116A1 (en) * | 2000-12-11 | 2002-06-24 | Takeda Chemical Industries Ltd. | Medicinal compositions having improved water-solubility |
US20040019096A1 (en) * | 2001-10-23 | 2004-01-29 | Vlassios Andronis | Novel formulations of carvedilol |
WO2003099773A1 (fr) | 2002-05-24 | 2003-12-04 | Millennium Pharmaceuticals, Inc. | Inhibiteurs de ccr9 et utilisation de ceux-ci |
TW200418812A (en) * | 2002-10-29 | 2004-10-01 | Smithkline Beecham Corp | IL-8 receptor antagonists |
US7741519B2 (en) | 2007-04-23 | 2010-06-22 | Chemocentryx, Inc. | Bis-aryl sulfonamides |
DK1798223T4 (da) | 2002-11-18 | 2014-09-22 | Chemocentryx Inc | Arylsulfonamider |
US7420055B2 (en) | 2002-11-18 | 2008-09-02 | Chemocentryx, Inc. | Aryl sulfonamides |
US7227035B2 (en) | 2002-11-18 | 2007-06-05 | Chemocentryx | Bis-aryl sulfonamides |
SE0303480D0 (sv) * | 2003-12-19 | 2003-12-19 | Biovitrum Ab | Benzofuranes |
EP1742635B1 (fr) * | 2004-04-20 | 2018-03-07 | Acea Biosciences, Inc. | Composes organosulfures substitues et leurs procedes d'utilisation |
WO2007100066A1 (fr) * | 2006-03-02 | 2007-09-07 | Astellas Pharma Inc. | INHIBITEUR DE LA 17β HSD DE type 5 |
UA98456C2 (en) * | 2006-04-21 | 2012-05-25 | Смитклайн Бичам Корпорейшн | Il-8 receptor antagonists |
AU2007240364A1 (en) * | 2006-04-21 | 2007-11-01 | Smithkline Beecham Corporation | IL-8 receptor antagonists |
AR061571A1 (es) * | 2006-06-23 | 2008-09-03 | Smithkline Beecham Corp | Compuesto sal del acido toluenosulfonico de 4-{[6-cloro-3-({[(2- cloro-3-fluorofenil) amino]carbonil} amino)- 2- hidroxifenil]sulfonil] -1- piperazinacarbxilato de 1.1-dimetiletilo, composicion farmaceutica que lo comprende su uso para la fabricacion de un medicamento combinacion farmaceutica con un |
US7785218B2 (en) | 2007-03-26 | 2010-08-31 | Acushnet Company | Custom milled iron set |
WO2011062955A2 (fr) * | 2009-11-18 | 2011-05-26 | University Of Massachusetts | Composés pour la modulation de tlr2 |
CN104529830B (zh) * | 2015-01-15 | 2016-08-24 | 成都丽凯手性技术有限公司 | 一种制备脲类化合物的新方法 |
GB201521059D0 (en) * | 2015-11-30 | 2016-01-13 | Isis Innovation | Inhibitors of metallo-beta-lactamases |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1054655B (it) * | 1975-08-27 | 1981-11-30 | Lepetit Spa | Derivati condensati del l isochinolina |
FR2375228A1 (fr) * | 1976-12-23 | 1978-07-21 | Parcor | Nouveaux benzothiophenes, leurs procedes de preparation et leur application notamment comme hypolipemiants et hypocholesterolemiants |
JPH0753714B2 (ja) * | 1988-07-12 | 1995-06-07 | 武田薬品工業株式会社 | Acat阻害剤、キノリン誘導体及びその製造法 |
CN1028754C (zh) * | 1988-07-12 | 1995-06-07 | 武田药品工业株式会社 | 喹啉衍生物的制备方法 |
AU632809B2 (en) * | 1989-05-25 | 1993-01-14 | Takeda Chemical Industries Ltd. | Benzocycloalkane benzopyran and benzothiopyran urea derivatives and production thereof |
FR2674522B1 (fr) * | 1991-03-26 | 1993-07-16 | Lipha | Nouveaux derives de l'indole, procedes de preparation et medicaments les contenant. |
IL101785A0 (en) * | 1991-05-10 | 1992-12-30 | Fujisawa Pharmaceutical Co | Urea derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same |
WO1993024458A1 (fr) * | 1992-05-28 | 1993-12-09 | Pfizer Inc. | Nouveau derives n-aryle et de n-heteroaryluree en tant qu'inhibiteurs de l'acylcoenzime a: cholesterol acyltransferase (acat) |
TW234123B (fr) * | 1992-12-16 | 1994-11-11 | Takeda Pharm Industry Co Ltd |
-
1994
- 1994-02-18 NZ NZ250916A patent/NZ250916A/en unknown
- 1994-02-23 CA CA002116286A patent/CA2116286A1/fr not_active Abandoned
- 1994-02-24 AU AU56364/94A patent/AU679021B2/en not_active Ceased
- 1994-02-25 ES ES94102905T patent/ES2133430T3/es not_active Expired - Lifetime
- 1994-02-25 TW TW083101626A patent/TW279858B/zh active
- 1994-02-25 DK DK94102905T patent/DK0613894T3/da active
- 1994-02-25 KR KR1019940003513A patent/KR940019701A/ko not_active Application Discontinuation
- 1994-02-25 EP EP94102905A patent/EP0613894B1/fr not_active Expired - Lifetime
- 1994-02-25 AT AT94102905T patent/ATE179706T1/de not_active IP Right Cessation
- 1994-02-25 DE DE69418243T patent/DE69418243T2/de not_active Expired - Fee Related
- 1994-02-26 CN CN94101930A patent/CN1051311C/zh not_active Expired - Fee Related
- 1994-02-27 JP JP06052797A patent/JP3143766B2/ja not_active Expired - Fee Related
- 1994-09-24 US US08/201,378 patent/US5464863A/en not_active Ceased
-
1998
- 1998-06-19 US US09/100,241 patent/USRE36832E/en not_active Expired - Fee Related
-
1999
- 1999-05-07 GR GR990401227T patent/GR3030165T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
DE69418243T2 (de) | 1999-09-30 |
TW279858B (fr) | 1996-07-01 |
JPH06340647A (ja) | 1994-12-13 |
EP0613894B1 (fr) | 1999-05-06 |
DE69418243D1 (de) | 1999-06-10 |
CA2116286A1 (fr) | 1994-08-28 |
ATE179706T1 (de) | 1999-05-15 |
AU679021B2 (en) | 1997-06-19 |
CN1051311C (zh) | 2000-04-12 |
US5464863A (en) | 1995-11-07 |
NZ250916A (en) | 1995-08-28 |
ES2133430T3 (es) | 1999-09-16 |
AU5636494A (en) | 1994-09-01 |
EP0613894A1 (fr) | 1994-09-07 |
USRE36832E (en) | 2000-08-22 |
GR3030165T3 (en) | 1999-08-31 |
CN1100417A (zh) | 1995-03-22 |
JP3143766B2 (ja) | 2001-03-07 |
KR940019701A (ko) | 1994-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0613894T3 (da) | N-Heteroaryl-N'-phenylurinstofderivater, fremstilling og anvendelse deraf | |
HU9600834D0 (en) | Quinazoline derivatives | |
ATE223378T1 (de) | Prolineamid-derivate | |
PT850926E (pt) | Derivados da difluoroprostaglandina e sua utilizacao | |
DK0923554T3 (da) | N-Benzylpiperidin- og tetrahydropyridinderivater | |
FI920023A0 (fi) | Heteroarylpiperazinfoereningar som antipsykotiska aemnen. | |
DE69200290D1 (de) | Thienopyridin -Derivative und diese enthaltende Arzneimittel. | |
DK0508740T3 (da) | Thiazolidindionderivater, deres fremstilling og anvendelse. | |
DE68922537D1 (de) | Antipsychotische 3-Piperazinylbenzazolderivate. | |
ES2055235T3 (es) | Composicion anti-inflamatoria y/o antialergica que comprende derivados de glutation. | |
ES2106058T3 (es) | Derivados de benzamida. | |
HU9400908D0 (en) | Pharmaceutical compositions for treatng skin disorders | |
AU631209B2 (en) | Carboxamide derivatives | |
HUT75124A (en) | Use of bicyclolactam derivatives for producing pharmaceutical compositions having anxiolytic activity | |
AU7589298A (en) | 5-{(heteroaryl)alkyl}-3-oxo-pyrido{1,2-(a)}benzimidazole-4-c arboxamide derivatives useful in treating central nervous system disorders | |
EP0381508A3 (en) | Use of cinnamamide for relaxing muscle tone | |
DK0784973T3 (da) | Quinoxalinderivater til behandling af tinnitus |